B My Cheung1, C H Cheng2, C P Lau3, C Ky Wong4, R Cw Ma5, D Ws Chu2, D Hk Ho4, K Lf Lee2, H F Tse1, A Sp Wong2, B Py Yan5, V Wt Yan2. 1. Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong. 2. Private practice, Hong Kong. 3. Institute of Cardiovascular Science and Medicine, The University of Hong Kong, Pokfulam, Hong Kong. 4. Hong Kong Sanatorium & Hospital, Happy Valley, Hong Kong. 5. Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.
Abstract
INTRODUCTION: In Hong Kong, the prevalence of atherosclerotic cardiovascular disease has increased markedly over the past few decades, and further increases are expected. In 2008, the Hong Kong Cardiovascular Task Force released a consensus statement on preventing cardiovascular disease in the Hong Kong population. The present article provides an update on these recommendations. PARTICIPANTS: A multidisciplinary group of clinicians comprising the Hong Kong Cardiovascular Task Force-10 cardiologists, an endocrinologist, and a family physician-met in September 2014 and June 2015 in Hong Kong. EVIDENCE: Guidelines from the American College of Cardiology/American Heart Association, the European Society of Hypertension/European Society of Cardiology, and the Eighth Joint National Committee for the Management of High Blood Pressure were reviewed. CONSENSUS PROCESS: Group members reviewed the 2008 Consensus Statement and relevant international guidelines. At the meetings, each topical recommendation of the 2008 Statement was assessed against the pooled recommendations on that topic from the international guidelines. A final recommendation on each topic was generated by consensus after discussion. CONCLUSIONS: It is recommended that a formal risk scoring system should be used for risk assessment of all adults aged 40 years or older who have at least one cardiovascular risk factor. Individuals can be classified as having a low, moderate, or high risk of developing atherosclerotic cardiovascular disease, and appropriate interventions selected accordingly. Recommended lifestyle modifications include adopting a healthy eating pattern; maintaining a low body mass index; quitting smoking; and undertaking regular, moderate-intensity physical activity. Pharmacological interventions should be selected as appropriate after lifestyle modification.
INTRODUCTION: In Hong Kong, the prevalence of atherosclerotic cardiovascular disease has increased markedly over the past few decades, and further increases are expected. In 2008, the Hong Kong Cardiovascular Task Force released a consensus statement on preventing cardiovascular disease in the Hong Kong population. The present article provides an update on these recommendations. PARTICIPANTS: A multidisciplinary group of clinicians comprising the Hong Kong Cardiovascular Task Force-10 cardiologists, an endocrinologist, and a family physician-met in September 2014 and June 2015 in Hong Kong. EVIDENCE: Guidelines from the American College of Cardiology/American Heart Association, the European Society of Hypertension/European Society of Cardiology, and the Eighth Joint National Committee for the Management of High Blood Pressure were reviewed. CONSENSUS PROCESS: Group members reviewed the 2008 Consensus Statement and relevant international guidelines. At the meetings, each topical recommendation of the 2008 Statement was assessed against the pooled recommendations on that topic from the international guidelines. A final recommendation on each topic was generated by consensus after discussion. CONCLUSIONS: It is recommended that a formal risk scoring system should be used for risk assessment of all adults aged 40 years or older who have at least one cardiovascular risk factor. Individuals can be classified as having a low, moderate, or high risk of developing atherosclerotic cardiovascular disease, and appropriate interventions selected accordingly. Recommended lifestyle modifications include adopting a healthy eating pattern; maintaining a low body mass index; quitting smoking; and undertaking regular, moderate-intensity physical activity. Pharmacological interventions should be selected as appropriate after lifestyle modification.
Entities:
Keywords:
Cardiovascular diseases/prevention & control; Hong Kong
Authors: Natalie Koh; Brian A Ference; Stephen J Nicholls; Ann Marie Navar; Derek P Chew; Karam Kostner; Ben He; Hung Fat Tse; Jamshed Dalal; Anwar Santoso; Junya Ako; Hayato Tada; Jin Joo Park; Mei Lin Ong; Eric Lim; Tavin Subramaniam; Yi-Heng Li; Arintaya Phrommintikul; S S Iyengar; Saumitra Ray; Kyung Woo Park; Hong Chang Tan; Narathip Chunhamaneewat; Khung Keong Yeo; Jack Wei Chieh Tan Journal: Eur Cardiol Date: 2021-12-09
Authors: Stephen Franklin Weng; Ralph Kwame Akyea; Kenneth Kc Man; Wallis C Y Lau; Barbara Iyen; Joseph Edgar Blais; Esther W Chan; Chung Wah Siu; Nadeem Qureshi; Ian C K Wong; Joe Kai Journal: PLoS One Date: 2021-12-02 Impact factor: 3.240